- Home
- EXAS vs SKM Comparison
EXAS vs SKM Comparison
Compare EXAS & SKM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EXAS
- SKM
- Stock Information
- Founded
- EXAS 1995
- SKM 1984
- Country
- EXAS United States
- SKM South Korea
- Employees
- EXAS N/A
- SKM N/A
- Industry
- EXAS Medical Specialities
- SKM Telecommunications Equipment
- Sector
- EXAS Health Care
- SKM Telecommunications
- Exchange
- EXAS Nasdaq
- SKM Nasdaq
- Market Cap
- EXAS 10.1B
- SKM 8.6B
- IPO Year
- EXAS N/A
- SKM 1996
- Fundamental
- Price
- EXAS $48.49
- SKM $22.22
- Analyst Decision
- EXAS Strong Buy
- SKM Hold
- Analyst Count
- EXAS 20
- SKM 1
- Target Price
- EXAS $70.26
- SKM N/A
- AVG Volume (30 Days)
- EXAS 2.6M
- SKM 408.9K
- Earning Date
- EXAS 08-06-2025
- SKM 08-05-2025
- Dividend Yield
- EXAS N/A
- SKM 3.82%
- EPS Growth
- EXAS N/A
- SKM 10.48
- EPS
- EXAS N/A
- SKM 3.95
- Revenue
- EXAS $2,828,128,000.00
- SKM $12,191,932,706.00
- Revenue This Year
- EXAS $14.61
- SKM $1.65
- Revenue Next Year
- EXAS $12.65
- SKM $1.59
- P/E Ratio
- EXAS N/A
- SKM $10.14
- Revenue Growth
- EXAS 11.57
- SKM 1.21
- 52 Week Low
- EXAS $39.97
- SKM $19.84
- 52 Week High
- EXAS $72.83
- SKM $24.58
- Technical
- Relative Strength Index (RSI)
- EXAS 38.76
- SKM 47.77
- Support Level
- EXAS $48.15
- SKM $22.15
- Resistance Level
- EXAS $53.95
- SKM $22.74
- Average True Range (ATR)
- EXAS 2.10
- SKM 0.23
- MACD
- EXAS -0.51
- SKM -0.07
- Stochastic Oscillator
- EXAS 4.39
- SKM 38.95
About EXAS Exact Sciences Corporation
Exact Sciences, headquartered in Madison, Wisconsin, provides cancer screening and diagnostic test products in the United States and internationally. Exact's Cologuard screening test is a noninvasive stool-based DNA test for colorectal cancer. The company also competes in the precision oncology market with Oncotype DX, a suite of tissue-based genomic tests for estimating recurrence risk and likelihood of benefit from chemotherapy for breast and colon cancer, and OncoExTra, a liquid-based comprehensive genomic profiling test. It is also developing liquid biopsy tests for molecular residual disease, colorectal cancer screening, and multicancer screening.
About SKM SK Telecom Co. Ltd.
SK Telecom is South Korea's largest wireless telecom operator, with 32 million mobile customers. The firm also owns SK Broadband (formerly Hanaro Telecom), which has 7.2 million broadband customers and 9.6 million pay TV customers (6.8 million IPTV and 2.8 million Cable TV). While the firm also purchased stakes in businesses in security and semiconductor memory production as well as developing e-commerce and internet platform businesses, these were all spun off into the separate, SK Square business in November 2021. The company was formed after SK Group purchased KT's mobile business in 1994.